Jon Cacicedo Selected Research

Spinal Cord Compression

5/2022	Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression-An Additional Analysis of Patients from Two Prospective Trials.
1/2021	Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials.
1/2020	Precision Radiation Therapy for Metastatic Spinal Cord Compression: Final Results of the PRE-MODE Trial.
11/2019	Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study.
1/2019	Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.
1/2018	Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial.
12/2017	High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study.
6/2017	Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression.
3/2017	Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression.
9/2016	Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jon Cacicedo Research Topics

Disease

14	Spinal Cord Compression 05/2022 - 10/2015
9	Neoplasms (Cancer) 07/2022 - 09/2012
7	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 03/2014
7	Neoplasm Metastasis (Metastasis) 12/2020 - 08/2015
7	Pain (Aches) 12/2020 - 10/2015
5	Head and Neck Neoplasms (Head and Neck Cancer) 05/2020 - 02/2014
4	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2015
3	Weight Loss (Weight Reduction) 01/2021 - 09/2012
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 11/2016
1	Ototoxicity 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Fatigue 12/2020
1	Neuralgia (Stump Neuralgia) 12/2020
1	Dermatitis 05/2020
1	Radiodermatitis 05/2020
1	Stomatitis 05/2020
1	AIDS-Related Complex (ARC) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Lymphoma (Lymphomas) 06/2016
1	Breast Neoplasms (Breast Cancer) 08/2015
1	Extranodal Extension 06/2014
1	Proctitis 03/2014
1	Hemorrhage 03/2014
1	Carcinoma (Carcinomatosis) 02/2014

Drug/Important Bio-Agent (IBA)

2	Analgesics (Analgesic Drugs)IBA 11/2019 - 10/2015
2	Choline (Choline Chloride)IBA 09/2019 - 12/2016
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Tapentadol FDA Link 12/2020
1	IS 33IBA 11/2019
1	NucleotidesIBA 01/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019
1	Diphosphonates (Bisphosphonates)IBA 05/2018
1	Immunoglobulin G (IgG)IBA 01/2016
1	altersolanol AIBA 10/2015
1	Thymidine Monophosphate (TMP)IBA 08/2015
1	Cetuximab (Erbitux)FDA Link 06/2014

Therapy/Procedure

28	Radiotherapy 05/2022 - 09/2012
5	Brachytherapy 02/2021 - 06/2014
5	Drug Therapy (Chemotherapy) 01/2019 - 09/2012
2	Therapeutics 07/2022 - 01/2020
2	Salvage Therapy 02/2021 - 09/2019
2	Prostatectomy (Retropubic Prostatectomy) 12/2016 - 03/2014
2	Re-Irradiation 06/2014 - 02/2014
2	Aftercare (After-Treatment) 04/2014 - 09/2012
1	Skin Care 05/2020
1	Adjuvant Radiotherapy 05/2020
1	Immunotherapy 12/2018
1	Argon Plasma Coagulation 03/2014